- Home
- MCRB vs HITI Comparison
MCRB vs HITI Comparison
Compare MCRB & HITI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRB
- HITI
- Stock Information
- Founded
- MCRB 2010
- HITI 2009
- Country
- MCRB United States
- HITI Canada
- Employees
- MCRB N/A
- HITI N/A
- Industry
- MCRB Biotechnology: Pharmaceutical Preparations
- HITI
- Sector
- MCRB Health Care
- HITI
- Exchange
- MCRB Nasdaq
- HITI Nasdaq
- Market Cap
- MCRB 165.3M
- HITI 178.6M
- IPO Year
- MCRB 2015
- HITI N/A
- Fundamental
- Price
- MCRB $17.23
- HITI $3.60
- Analyst Decision
- MCRB Hold
- HITI Strong Buy
- Analyst Count
- MCRB 4
- HITI 2
- Target Price
- MCRB $73.67
- HITI $4.75
- AVG Volume (30 Days)
- MCRB 245.5K
- HITI 1.3M
- Earning Date
- MCRB 11-12-2025
- HITI 09-15-2025
- Dividend Yield
- MCRB N/A
- HITI N/A
- EPS Growth
- MCRB N/A
- HITI N/A
- EPS
- MCRB 10.22
- HITI N/A
- Revenue
- MCRB N/A
- HITI $410,600,094.00
- Revenue This Year
- MCRB N/A
- HITI $12.28
- Revenue Next Year
- MCRB N/A
- HITI $21.83
- P/E Ratio
- MCRB $1.68
- HITI N/A
- Revenue Growth
- MCRB N/A
- HITI 11.18
- 52 Week Low
- MCRB $6.53
- HITI $1.64
- 52 Week High
- MCRB $24.67
- HITI $3.99
- Technical
- Relative Strength Index (RSI)
- MCRB 52.55
- HITI 65.78
- Support Level
- MCRB $17.00
- HITI $3.24
- Resistance Level
- MCRB $24.67
- HITI $3.99
- Average True Range (ATR)
- MCRB 1.79
- HITI 0.19
- MACD
- MCRB -1.40
- HITI -0.00
- Stochastic Oscillator
- MCRB 69.86
- HITI 56.55
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
About HITI High Tide Inc.
High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, Famous Brandz, and others. The company's reportable operating segments are; Bricks and mortar which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada followed by the United States of America, and other international markets.